Brimonidine Tartrate; Brinzolamide Patent Expiration

Brimonidine Tartrate; Brinzolamide is Used for reducing elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension. It was first introduced by Alcon Laboratories Inc in its drug Simbrinza on Apr 19, 2013.


Brimonidine Tartrate; Brinzolamide Patents

Given below is the list of patents protecting Brimonidine Tartrate; Brinzolamide, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Simbrinza US6316441 Brinzolamide and brimonidine for treating glaucoma Dec 07, 2019

(Expired)

Alcon Labs Inc
Simbrinza US9044484 Aqueous pharmaceutical compositions containing borate-polyol complexes Oct 30, 2030 Alcon Labs Inc
Simbrinza US9421265 Aqueous pharmaceutical compositions containing borate-polyol complexes Jun 17, 2030 Alcon Labs Inc


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳